Related Experiment Videos

A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1

R W Johnstone1, R H See, S F Sells

  • 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

Researchers discovered par-4, a protein that interacts with the tumor suppressor WT1. Par-4 modulates WT1

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Transcriptional Regulation

Background:

  • The Wilms tumor suppressor (WT1) protein exhibits dual transcriptional activity (repression and activation).
  • Dysregulation of WT1's transcriptional functions is implicated in Wilms tumor development.
  • Prostate apoptosis response gene-4 (par-4) is a known transcriptional repressor upregulated during prostate cell apoptosis.

Purpose of the Study:

  • To identify novel WT1-interacting proteins.
  • To investigate the functional consequences of WT1-par-4 interaction on WT1's transcriptional and growth-suppressive activities.

Main Methods:

  • Co-immunoprecipitation and Western blotting to confirm in vivo interaction between WT1 and par-4.
  • Yeast two-hybrid assays to map the interaction domains (par-4 leucine repeat and WT1 zinc finger).
  • Reporter gene assays to assess the effect of par-4 on WT1-mediated transcription.
  • Growth suppression assays using WT1 and par-4 (wild-type and mutant).

Main Results:

  • Par-4 directly interacts with WT1 through its leucine repeat domain and WT1's zinc finger DNA-binding domain.
  • Par-4 inhibits WT1-activated transcription and enhances WT1-mediated repression.
  • Par-4's transcriptional repressor activity is dependent on its interaction domain with WT1.
  • Par-4, but not a non-interacting mutant, rescues WT1-induced growth suppression.

Conclusions:

  • Par-4 is a novel WT1-interacting protein that modulates both the transcriptional and growth-suppressive functions of WT1.
  • The interaction between par-4 and WT1 plays a significant role in regulating cellular processes relevant to cancer, particularly Wilms tumor.
  • Par-4 represents a potential therapeutic target for cancers associated with WT1 dysregulation.

Related Concept Videos